AVE avecho biotechnology limited

Share Price After Award Decision, page-9

  1. 694 Posts.
    lightbulb Created with Sketch. 167
    There might be a few other fearful types that may agree with your line of thinking sandy1066 however the suggestion feels more like a strategy to snatch defeat from the jaws of victory.


    Everyone is entitled to a point of view, mine is simply more optimistic than yours.


    With a commercial product, daptomycin, virtually ready to go and a list of valuable and quick to market injectibles POH's future would look very robust indeed with a healthy arbitration award. In addition POH have a meeting lined up with FDA for direction on appropriate development of our pain patches through the impending approval process.



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $14.28M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $1.437K 313.7K

Buyers (Bids)

No. Vol. Price($)
31 24165599 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28082733 24
View Market Depth
Last trade - 15.41pm 28/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.